ask="46.60"
ask_size="100"
average_daily_volume="1099270"
bid="37.50"
bid_size="100"
book_value="3.62"
change="+0.90"
change_from_200_day_moving_average="-2.12"
change_from_50_day_moving_average="2.32"
change_from_52_week_high="-11.10"
change_From_52_week_low="11.87"
change_in_percent="+2.09%"
close="44.05"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-146.03M"
eps_estimate_current_year="-2.25"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.20"
ex_dividend_date="N/A"
float_shares="85681000"
high="44.12"
high_52_weeks="55.15"
last_trade_date="2/17/2017"
last_trade_price="44.05"
last_trade_size="43282"
last_trade_time="4:00pm"
low="42.47"
low_52_weeks="32.18"
market_capitalization="3.83B"
moving_average_200_day="46.17"
moving_average_50_day="41.73"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="42.90"
pe_ratio="N/A"
peg_ratio="0.53"
percent_change_from_200_day_moving_average="-4.59%"
percent_change_from_50_day_moving_average="+5.56%"
percent_change_from_52_week_high="-20.13%"
percent_change_from_52_week_low="+36.89%"
previous_close="43.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="11.90"
price_per_sales="249.91"
revenue="15.00M"
shares_outstanding="86874000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="617977"
weeks_range_52="32.18 - 55.15"
